Opexa Therapeutics Inc Share Price Nasdaq
Equities
US68372T3014
Biotechnology & Medical Research
Latest transcript on Opexa Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 11-16 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 31/05/21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 11-16 |
Joshua Schafer
BRD | Director/Board Member | 53 | 11-16 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+23.78% | 27.87B | |
-17.74% | 20.95B | |
-15.41% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |